Brief: Genor Biopharma Posts FY Loss Of RMB730.4 Million
30/03/2023 16:33
March 30 (Reuters) - Genor Biopharma Holdings Ltd
6998.HK :
* FY LOSS RMB730.4 MILLION VERSUS RMB865.4 MILLION
* FY REVENUE RMB15.9 MILLION
Source text for Eikon: ID:nHKS9HkpzD
Further company coverage: 6998.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edding Genor group
See all newsBrief: Edding Genor Says CEO Initiates Plan To Purchase Additional Shares In Open Market
Brief: Edding Genor Posts Net Profit Increased To Rmb399.3 Million In 2025
Brief: Genor Biopharma Says NMPA Granted New Drug Application Approval For Lerociclib (Gb491)
Brief: Genor Biopharma, Its Unit & Edding Group Entered Into Merger Agreement
Brief: Genor Biopharma Says Guo Feng Tendered His Resignation As Chairman